November 7, 2025 · Form 4 insider transaction
SUVRETTA CAPITAL MANAGEMENT, LLC bought 730,370 shares of BENITEC BIOPHARMA INC at $13.50 per share, a transaction worth $9.86M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.